Clinical Trials for Kazia Therapeutics

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Kazia Therapeutics

Clinical Trials (6)

NCT06208657
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
PHASE1/PHASE2Recruiting
82 participants
Started: Jul 10, 2024 · Completed: Dec 31, 2035
5 conditions6 sponsors11 locations
NCT05183204
Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma
PHASE2Recruiting
33 participants
Started: Feb 14, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04906096
Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL
PHASE2Recruiting
25 participants
Started: Jun 1, 2021 · Completed: Dec 1, 2027
2 conditions2 sponsors2 locations
NCT04192981
GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases
PHASE1Active, not recruiting
21 participants
Started: Dec 6, 2019 · Completed: Dec 31, 2026
2 conditions2 sponsors9 locations
NCT03970447
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
PHASE2/PHASE3Recruiting
1,280 participants
Started: Jul 30, 2019 · Completed: Jun 30, 2030
1 condition8 sponsors62 locations
NCT03765983
GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases
PHASE2Active, not recruiting
47 participants
Started: Feb 11, 2019 · Completed: Nov 30, 2025
1 condition2 sponsors1 location